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Background
Airway inflammation in asthma can be subdivided in
Th2-high and Th2-low.
Objective
To identify unique patient clusters with a specific airway
cytokine expression profile in an unselected population
with asthma.
Methods
Induced sputum and clinical records were analysed from
208 asthmatics and 80 healthy individuals. Cytokine-
high patients had cytokine mRNA levels above the 90th
percentile value in controls. Unsupervised hierarchical
clustering was used to determine unique cytokine-based
patient clusters.
Results
Cubic Clustering Criterion, pseudo F and t2 statistics
revealed a two- and a six-cluster model. The first cluster
(n=23) was found in both models and consists of patients
who present with an “IL-5-high and IL-17F-high” profile.
Patients with an “IL-4- or IL-13-high” profile did not
cluster in one single group. In the six-cluster model, the
“IL-17F-low” group was divided into 5 separate clusters:
“IL-5-high” profile (n=7), “IFN-g-high” profile (n=15),
“IL-6- and/or TNF-high” profile (n=15), “IL-22-high”
profile (n=15) and those patients that were low for all
preceding cytokines (n=130; cluster 6). “IL-17F- and
IL-5-high” patients had significantly lower FEV1 and
higher sputum neutrophils. Patients that were only “IL-4-
or IL-13-high” (cluster 6) had highest FENO levels and
sputum eosinophils.
Conclusion
Th2-high asthma can be subdivided in patients with
“IL-5-high and IL-17F-high” asthma and those with “IL-
4- or IL-13-high” asthma. The inflammatory pattern is
different between both groups. The former group is
characterized by mixed granulocytic airway inflamma-
tion whereas the latter group consists of patients with
eosinophilic airway inflammation.
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